Our Latest News


DePuy Synthes Launches Innovative Implant Solution for Femoral Neck Fixation Further Strengthening the Company’s Comprehensive Portfolio for the Repair of Hip and Femur Fractures

West Chester, PA – January 30, 2019 – Johnson & Johnson Medical Devices Companies* today announced that DePuy Synthes** is launching the Femoral Neck System, an innovative new implant solution for the repair of femoral neck fractures. Approximately 1.6 million hip fractures, specifically fractures that take place in the upper part of the femur or long thigh bone, occur worldwide annually, and femoral neck fractures represent approximately 50% of all reported hip fracture cases. These types of fractures are often associated with high mortality rates, along with significant loss of function in more than 50% of patients.


DePuy Synthes Announces Agreement with Ortho Development® Corporation to Promote its KASM® Knee Articulating Spacer Mold

OCTOBER 16, 2018 Warsaw, IN – Johnson & Johnson Medical Devices Companies* today announced that DePuy Synthes Sales, Inc. has entered into an exclusive agreement with Ortho Development® Corporation to co-promote in the U.S. its KASM® Knee Articulating Spacer Mold. This is a sterile, disposable cement spacer mold for patients who develop an infection after primary knee replacement. This new offering builds upon DePuy Synthes’** commitment to innovative knee solutions focused on helping patients along the care continuum.


DePuy Synthes Expands Spine Portfolio with Nerve Assessment Platform Designed to Identify & Avoid Nerves During Spine Surgery

Los Angeles – September 26, 2018 – Johnson & Johnson Medical Devices Companies* announced today that DePuy Synthes** is introducing SENTIO MMG, a first-of-its-kind digital mechanomyography platform designed to assess nerve status and identify and avoid peripheral nerves during spine surgery. SENTIO MMG enables motor nerve monitoring for a variety of spine procedures, including non-fusion procedures such as discectomy and both minimally invasive (MIS) and open spinal fusion surgery. SENTIO MMG is being broadly introduced at the 2018 North America Spine Society Meeting in Los Angeles, California.


Johnson & Johnson Medical GmbH Acquires Emerging Implant Technologies GmbH to Enhance Global Offering of Interbody Spine Implants

Norderstedt, Germany – September 12, 2018 – Johnson & Johnson Medical Devices Companies*, through its subsidiary Johnson & Johnson Medical GmbH, announced today the acquisition of Emerging Implant Technologies GmbH (EIT), a privately held manufacturer of 3D-printed titanium interbody implants for spinal fusion surgery, based in Wurmlingen, Germany. The products in this portfolio leverage EIT’s proprietary advanced cellular titanium, which consists of an open and interconnected porous structure designed to allow bone to grow into the implant. As industry leaders across the full range of orthopaedic and spine specialties, Johnson & Johnson Medical Devices Companies will leverage its global commercial infrastructure to bring EIT’s technologies to patients around the world.


New National Survey Uncovers the Surprising Impact that Knee and Hip Pain Has on Women’s Emotional Well-Being

WARSAW, Ind. – August 20, 2018 – While many who suffer from knee or hip pain know that it impacts their everyday activities, results from a new survey show the significant emotional impact of joint pain. This includes impact on romantic and social relationships, ability to pursue hobbies and overall mood. The survey of more than 500 women ages 45-65, including those who have had joint replacement surgery and those planning to have joint replacement surgery, revealed:


DePuy Synthes Launches CONCORDE LIFT Expandable Interbody Implant as Part of a New Procedural Solution for Minimally Invasive Spine Surgery (MIS) that Enhances Surgical Efficiency

Raynham, MA – July 26, 2018 – Johnson & Johnson Medical Devices Companies* today announced that DePuy Synthes** is launching the CONCORDE LIFT Expandable Interbody Device in the U.S. The CONCORDE LIFT Implant is designed to treat patients suffering from degenerative disc disease as part of the new offering called UNLEASH MIS TLIF (Transforaminal Lumbar Interbody Fusion) Procedural Solution. The complete system includes a comprehensive set of solutions to help simplify key stages of this surgery by enhancing surgical efficiency.